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Background. Multiple conduits for right ventricular outflow tract reconstruction exist, though the ideal 
conduit that maximizes outcomes remains controversial. We evaluated long-term outcomes and compared 
conduits for right ventricular outflow tract reconstruction in children with truncus arteriosus. 
Methods. Records of patients who underwent truncus arteriosus repair at our institution between 1981 and 
2018 were retrospectively reviewed. Primary outcomes included survival and freedom from catheter 
reintervention or reoperation. Secondary analyses evaluated the effect of comorbidity, operation era, 
conduit type, and conduit size. 
Results. One-hundred patients met inclusion criteria. Median follow-up time was 15.6 years (interquartile 
range, 5.3-22.2 years) Actuarial survival at 30 days, 5 years, 10 years, and 15 years was 85%, 72%, 72, 
and 68%, respectively. Early mortality was associated with concomitant interrupted aortic arch (HR 5.4; 
95% CI, 1.7-17.4; p=0.005). 
Median time to surgical reoperation was 4.6 years (n=58; interquartile range, 2.9-6.8 years). 
Right ventricle to pulmonary artery continuity was established with an aortic homograft (n=14), 
pulmonary homograft (n=41), or bovine jugular vein conduit (n=36) in most cases. Multivariate analysis 
revealed longer freedom from reoperation with the bovine jugular vein conduit compared to the aortic 
homograft (HR 3.1; 95% CI, 1.3-7.7; p=0.02) with no difference compared to the pulmonary homograft. 
Larger conduit size was associated with longer freedom from reoperation (HR 0.7; 95% CI, 0.6-0.9; 
p<0.001). 
Conclusions. The bovine jugular vein conduit is a favorable conduit for right ventricular outflow tract 
reconstruction in patients with truncus arteriosus. Concomitant interrupted aortic arch is a risk factor for 
early mortality. 





Glossary of Abbreviations   
 
 BJVC Bovine jugular vein conduit 
ECMO Extracorporeal membrane oxygenation 
IAA Interrupted aortic arch 
IQR Interquartile range 
RV-PA Right ventricle - pulmonary artery 
RVOT Right ventricular outflow tract 
TA Truncus arteriosus 
TA-IAA Truncus arteriosus with interrupted aortic arch 
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Truncus arteriosus (TA) is a rare congenital cardiac m lformation characterized by a single arterial 
trunk that arises from the base of the heart, overrid s the interventricular septum, and supplies the 
systemic, pulmonary, and coronary circulations. TA comprises an estimated 0.21-0.34% of all cases of 
congenital heart disease and presents with a right-s ded aortic arch or an interrupted aortic arch (IAA) in 
18-36% and 11-14% of cases, respectively.1 Other associated conditions include DiGeorge syndrome, 
atrioventricular septal defect (ASD), aortic coarcttion, and coronary artery anomalies. 
The ideal conduit for right ventricular outflow tract (RVOT) reconstruction during TA repair remains 
controversial. The aortic homograft was used in the first successful repair of TA and is still utilized in 
some institutions, though use of the aortic homograft has largely fallen out of favor due to a propensity 
for obstruction, early stenosis, and adherence to surr unding structures which increases difficulty of 
reoperation.2-4 Improved outcomes with longer freedom from conduit ysfunction and decreased graft 
calcification are reported with the pulmonary homograft.5,6 However, significant regurgitation and 
stenosis leading to early reoperation have been documented.7,8 
Due to concerns of limited durability, availability, and cost of homografts, attention has turned to 
alternative approaches. Some studies report beneficial outcomes using direct right ventricle to 
pulmonary artery (RV-PA) anastomosis for TA repair.9 RVOT reconstruction using porcine xenografts 
has been accomplished, though successful operations are often documented in older patients with 
recommended use beyond the neonatal period.10 The valved bovine jugular vein conduit 
(BJVC; Contegra, Medtronic, Minneapolis, MN) demonstrates hemodynamic and tissue handling 
properties similar to homografts, with additional benefits of natural continuity between the valve and
conduit, less obstruction and regurgitation, and favor ble long-term results when compared to other 




Given the controversy regarding the optimal conduit for TA repair, we aimed to compare survival and 
reintervention outcomes by conduit type for RVOT reconstruction in children undergoing TA repair at 
our institution. 
 
PATIENTS AND METHODS 
Patients 
All patients who underwent TA repair between Novembr 1981 and April 2018 at Riley Hospital 
for Children at Indiana University Health in Indianapolis, Indiana were included. Electronic medical 
records were retrospectively reviewed. This study was approved by the local institutional review board 
and due to the retrospective nature of this study, the need for informed consent was waived. 
Patients were grouped according to TA anatomy as defined by Collett and Edwards 
classification.24  Conduit function was assessed using transthoracic echocardiography with color and 
spectral Doppler patterns per the American Society of Echocardiography. Conduit failure was defined by 
moderate or greater valve incompetence and/or peak RV-PA gradient greater than or equal to 40 mmHg. 
In agreement with the Society of Thoracic Surgeons (STS) definition, early mortality was defined as 
death within the first 30 postoperative days or during the same hospitalization in which initial repair was 
performed. Primary outcomes included overall survival, freedom from catheter reintervention, and 
freedom from reoperation. Secondary analyses were performed to evaluate the effect of 
comorbidity, operation era, conduit type, and conduit size.  
 
Surgical technique 
Our technique of repair for truncus arteriosus has been previously described.2 Homograft size was 






conduit was cut as short as possible posteriorly and the left pleural space was opened widely to avoid 
sternal compression of the valve and prevent conduit valve regurgitation. 
Statistical analysis 
Data were analyzed using SPSS for Windows version 25 (SPSS, Inc., Chicago, IL) and R version 
3.5.0 (R Foundation for Statistical Computing, Vienna, Austria). Categorical data are listed as n (%) and 
continuous data are listed as median [interquartile range (IQR)]. The Kaplan-Meier product limit method 
and Cox proportional hazards regression methods were used for analysis of survival, freedom from 
catheter reintervention, and freedom from reoperation. Multiple regression analysis was performed as 
conditional backward stepwise proportional hazards regression. Mortality and operative reintervention 
were identified as competing risks, necessitating the development of a cause-specific Cox proportional 




During the study period, 103 patients with TA were valuated at our institution. Of these, 3 patients 
were excluded due to initial TA repair performed at an outside hospital (n=2) or definitive treatment with 
heart transplantation (n=1). The remaining 100 patients with primary repair in infancy were included in 
the analysis. Patient demographics are summarized in Table 1. 
 
Operative details 
In 84% of patients, TA repair was performed in the first 100 days of life, with a median age of 33 
days (IQR 20-71 days). The median weight at operation was 3.2 kg (IQR 2.8-4.0 kg). Total 
cardiopulmonary bypass duration ranged from 85 to 480 minutes (mean, 183 ± 73 min). Aortic cross-
clamp duration ranged from 23 to 247 minutes (mean, 89 ± 40 min). RV-PA continuity was established 
with a cryopreserved aortic homograft (n=14), cryopeserved pulmonary homograft (CryoLife, Inc., 
Kennesaw, GA) (n=41), bovine jugular vein conduit (Contegra, Medtronic Inc., Minneapolis, MN) 
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(n=36), valved heterograft conduit [woven Dacron graft containing a glutaraldehyde-preserved porcine 
valve (Medtronic, Inc., Minneapolis, MN)] (n=4), no-valved polytetrafluoroethylene (PTFE) tube (W.L. 
Gore & Associates, Inc., Naperville, IL) (n=3), or Gore-Tex monocusp (W.L. Gore & Associates, Inc., 
Naperville, IL) (n=1). In one case, direct anastomosis to the right ventricle was performed according to 
the technique described by Barbero-Marcial and associates.9 Median conduit diameter size was 12 mm 
(IQR 11-12 mm).  
Five patients underwent truncal valve repair at the tim  of initial TA repair. Aortic root replacement 
was performed in 1 patient using a 12 mm aortic homograft. A second patient underwent an aortic root 
replacement with concomitant Nicks aortic annular enlargement.25  Aortic valvuloplasty was performed in 
2 patients. One child underwent aortic valvuloplasty with conversion to aortic root replacement. 
 
Trends over time 
 Subgroup analysis by operation era revealed significa t trends over time at our institution (Table 
2). Earlier eras were associated with increased age and weight at initial repair and decreased 30-day 
survival compared to operations performed in later eras. Our preference of conduit material for RVOT 
reconstruction technique has also changed over time. The aortic homograft, Dacron valved porcine 
conduit, non-valved PTFE tube, and direct anastomosis techniques were used in the 1980s and early 
1990s. The pulmonary homograft was the conduit of ch ice in the 1990s and the second most common 
conduit used in the 2000s. Since 2000, the BJVC has been our conduit of choice for RVOT reconstruction 
for TA repair (Figure 1).  
Delayed sternal closure was performed for 43 patients. A significant association between delayed 










Excluding 26 patients who died in the first 2 post-perative years, patients were followed for a 
median of 15.6 years (IQR 5.3-22.2 years). No patient was lost to follow-up. Actuarial survival at 30 
days, 5 years, 10 years, and 15 years was 85%, 72%, 72 , and 68%, respectively. 
 
Mortality 
A total of 30 mortalities (30%) occurred after trunc s arteriosus repair (Table 3). There were 16 early 
mortalities (16%) that occurred at a median interval of 7 days (IQR 0-18 days) after TA repair. 
Cardiovascular complications were the most common cause of early mortality, occurring in 12 patients 
(75% of early deaths). Univariate analysis revealed  significant relationship between early mortality and 
cardiopulmonary bypass duration (p<0.001), aortic cross-clamp duration (p=0.001), concomitant neo-
aortic valve repair (p<0.01), operations performed in the 1980s (p=0.006), and TA-IAA (p=0.001). 
Statistical significance of the hazard association of TA-IAA was maintained on multivariate analysis (HR 
5.4; 95% confidence limit, 1.7-17.4; p=0.005) (Table 4).  
Late mortality occurred in 14 patients (14%). Of these, 10 patients (71%) died within the first 2 
postoperative years, with an additional 4 deaths occurring at postoperative years 3, 12, 14, and 17. 
Mortality due to cardiovascular complications occurred in 1 patient who experienced cardiac arrest on 
postoperative day 61 following an apneic event at home, though surgical repairs were intact. Additional 
causes of late mortality included acute respiratory distress syndrome (21%) and sepsis (29%), none of 







Early reoperations, defined as cardiac reoperations for events other than delayed sternal closure 
during the post-TA repair hospitalization, occurred in 11 patients. Indications for early re-operation 
included re-exploration for mediastinal bleeding and cardiac tamponade in 8 patients; low cardiac output 
syndrome status-post delayed sternal closure in 1 patient; and open cardiac massage for low cardiac 
output in 2 patients, 1 of whom succumbed to cardiac arrest. Postoperative ECMO support was required 
for 14 patients, 1 of whom died while on ECMO support. 
 
Reintervention 
Median time to surgical or catheter reintervention was 3.8 years (n=61; IQR 0.7-6.4 years) and 
actuarial freedom from surgical or catheter reintervention was 88%, 77%, and 44% at 6 months, 1 year, 
and 5 years, respectively. Between TA repair and the first reoperation for RVOT reconstruction, catheter 
reintervention was performed in 23 patients. Median freedom from catheter reintervention in these 23 
patients was 0.6 years (IQR 0.2-2.3 years). Indications for catheter reintervention included conduit failure 
(n=5), branch pulmonary artery stenosis (n=10), and both conduit failure and branch pulmonary artery 
stenosis (n=8). Several variables were analyzed as potential risk factors for catheter reintervention, but no 
significance was identified on univariate and multivar ate analyses (Table 5).  
 
Reoperation 
RVOT reoperation occurred in 58 patients. Median time to surgical reoperation was 4.6 years (IQR 
2.9-6.8 years). Actuarial freedom from reoperation was 88%, 43%, and 5% at 1, 5, and 10 years, 
respectively. In most cases, the primary indication for reoperation was conduit failure (n=55). Two 
patients underwent RVOT reconstruction at the time of aortic valve repair but did not meet full critera for 
conduit failure. One patient underwent reoperation due to endocarditis on a 20-month-old 12 mm BJVC. 
No patient died during reoperation. Currently, 13 patients are alive and have not yet required re-operation, 
with median freedom from reoperation of 3.2 years (IQR 2.1-6.7 years). 
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Kaplan-Meier analysis demonstrated a significant relationship between conduit material and freedom 
from reoperation (Figure 2). Following initial TA repair, patients who received a BJVC experienced 
longer freedom from reoperation overall compared to patients who received either an aortic or pulmonary 
homograft (p=0.05).  
Univariate and multivariate analyses revealed a significant relationship between conduit material and 
freedom from reoperation. Compared to the BJVC, patients who received the aortic homograft exhibited 
shorter freedom from reoperation (HR 3.1; 95% confidence limit, 1.3-7.7; p=0.02), but no significant 
difference was observed with the pulmonary homograft (HR 1.8; 95% confidence limit, 0.9-3.6; p=0.10). 
A competing risks model of mortality and freedom from reoperation in relation to conduit material 
revealed a similar relationship regarding freedom from reoperation. Compared to the BJVC, the aortic 
homograft underperformed (HR 3.8; 95% confidence limit, 1.1-14.0; p=0.04) while no significant 
difference was observed with the pulmonary homograft (HR 2.1; 95% confidence limit, 0.8-5.8, p=0.15). 
Larger conduit size was associated with decreased ri k of reoperation compared to smaller conduit size
(HR 0.7; 95% confidence limit, 0.6-0.9; p<0.001) (Table 6).  
 
COMMENT 
This study serves as an extension upon our previous report of TA repair at Riley Hospital for Children 
at Indiana University Health.2 To our knowledge, this is the largest single-center i vestigation of the 
effect of conduit material on freedom from reintervention in children with TA. Previous published reports 
on RVOT reconstruction with the BJVC demonstrate favor ble results.11-19 In the present study, RVOT 
reconstruction with BJVC exhibited longer freedom from reoperation compared to the aortic homograft, 
with no difference compared to the pulmonary homograft. Given the increased cost, decreased supply, 
and limited size availability of aortic and pulmonary homografts, the BJVC offers a favorable alternative 
for RVOT reconstruction.  
Among 36 patients who received the BJVC at initial TA repair, 1 case (2.8%) of endocarditis was 
reported. At our institution, the rate of endocarditis in the BJVC is lower in the truncus arteriosus 
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population, possibly due to younger patient age at initial repair and time to reoperation. We recently 
published a retrospective institutional review of 315 BJVCs placed during RVOT reconstruction.18 A total 
of 21 cases (6.6%) of endocarditis were reported, half of which were managed with antibiotic therapy 
alone. Mery et al. evaluated risk factors for endocarditis and reintervention among 792 valved conduits 
placed during RVOT reconstruction.19 Although the BJVC was identified as a risk factor for endocarditis, 
it was associated with a lower risk for reinterventio  and replacement compared to other conduit types. 
We have observed long-term favorable outcomes with the BJVC at our institution, though our observed 
rate of endocarditis with the BJVC is consistent with other reports.19-21 
In our prior report published in 2001, several potential risk factors for early mortality were identified, 
yet only operation era and IAA were significant on multivariate analysis. Indeed, 17 years later, both 
variables remain significant risk factors for early mortality. As operation technique and surgical 
experience evolved, operative mortality has decreased in later decades. Associated IAA is a risk factor for 
early mortality following initial TA repair in this and other previous reports.26-29  Conversely, others do 
not identify IAA as a risk factor, and favorable long-term results with one-stage repair of TA-IAA have 
been reported.30-33 While uncommonly performed, concomitant neo-aortic valve repair was associated 
with early mortality similar to other reports.34,35 In contrast, a recent multicenter study of 216 patients 
reported no significant association with late mortality or major adverse cardiac event in 37 patients who 
underwent concomitant truncal valve repair.19,36 
Previous studies have indicated that conduit size may influence conduit longevity and overall freedom 
from reoperation. RVOT reconstruction using a conduit size with a Z-score between +1 and +3 leads to 






failure and shorter time to reintervention.19,37-40  In the present study, conduit size was not associated with 
early mortality or freedom from catheter reinterventio  but was associated with freedom from 
reoperation. Compared to smaller conduits, larger conduits were associated with decreased risk of 
reoperation. However, caution is advised against using excessively large conduits which may lead to 
obstruction (distal conduit buckling), turbulent flow, or regurgitation.  
There are several important limitations of this study. Due to the rarity of truncus arteriosus, this study 
is limited by sample size. As a retrospective study, information availability is limited to archived records 
and follow-up echocardiographic information was unavail ble for several patients. Also, records were 
recovered at a single institution where surgical technique and expertise may impact long-term results.  
In conclusion, our experience provides encouraging lo -term results for RVOT reconstruction in 
children with truncus arteriosus. Early mortality following initial repair has significantly declined in later 
operation eras, though risk may remain elevated in patients with TA-IAA.  Due to favorable cost, supply, 
and long-term results, the BJVC is an ideal conduit of choice for RVOT reconstruction in patients with 
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Table 1: Patient demographics 
 n 
Sex  
     Male 48 
     Female 52 
Truncus arteriosus anatomy  
     Type I 44 
     Type II 43 
     Type III 8 
     Type IV 0 
     Undefined 
Truncal valve anatomy 
     Bicuspid aortic valve 
     Tricuspid aortic valve 







     DiGeorge syndrome 




     Interrupted aortic arch, type B 6 
     Right-sided aortic arch 22 
     Patent ductus arteriosus 18 
     Coronary artery anomaly 9 
     Hypoplastic aortic arch 4 





Table 2: Patient demographics and operative outcomes by era 










Age (days) 102.5 (72-613) 29 (3-732) 26 (7-56) 40 (3-245) 





0 (0%) 8 (18%) 17 (74%) 18 (78%) 
Conduit Type AH: 4 (40%) 
PH: 1 (10%) 
PX: 3 (30%) 
NI: 1 (10%) 
DA: 1 (10%) 
AH: 9 (20%) 
PH: 30 (68%) 
BJVC: 1 (2%) 
PX: 1 (2%) 
MC: 1 (2%) 
NVG: 2 (5%) 
PH: 10 (43%) 
BJVC: 13 (57%) 
 
AH: 1 (4%) 
BJVC: 22 (96%) 
Conduit size 12.0 (8.0-19.0) 12.0 (9.0-19.0) 12.0 (10.0-12.0) 12.0 (9.0-14.0) 
30-day survival 6 (60%) 29 (66%) 15 (65%) 20 (87%) 
Numerical data are listed as median (range), categorical data listed as n (%) 
AH: aortic homograft; BJVC: bovine jugular venous conduit; DA: direct anastomosis; MC: monocusp; 
NVG: non-valved graft; PH: pulmonary homograft; PX: porcine xenograft  
20 
 
Table 3: Mortality after TA repair   





Unable to wean from bypass 2 0 
Unable to wean from mechanical ventilation 1 0 
Pulmonary hypertensive crisis 1 0 
Cardiac arrest 4 1 
Cardiogenic shock 5 0 
Acute respiratory distress syndrome 0 3 
Sepsis 2 4 
Cerebral herniation 0 1 




Table 4: Risk factors for early mortality  
Variable Univariate Multivariate 
 p value         HR                      95% CI                p value         
Age at operation  0.56    
Weight at operation 0.16    
TA-IAA  0.001 5.4 1.7-17.4 0.005 
Coronary artery anomaly 0.18    
Conduit material     
     Aortic homograft 0.06 2.2* 0.6-8.0 0.25 
     Pulmonary homograft 0.61 0.6* 0.2-2.2 0.40 
Conduit size 
Decade† 
     1980s 
     1990s 






   
*Compared to bovine jugular vein conduit (BJVC) 
†Compared to 2010s 
TA-IAA: Truncus arteriosus with interrupted aortic arch  
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Table 5: Risk factors for catheter reintervention 
Variable Univariate Multivariate 
 p value         HR 95% CI p value         
Age at operation (days) 0.39    
Weight at operation (kg) 0.84    
TA-IAA  0.99    
Coronary artery anomaly 0.87    
Conduit material     
     Aortic homograft 0.29 0.4* 0.1-2.0 0.29 
     Pulmonary homograft 0.18 0.6* 0.2-1.3 0.18 
Conduit size 
Decade† 
     1980s 
     1990s 






   
* Compared to bovine jugular vein conduit (BJVC) 
†Compared to 2010s 
TA-IAA: Truncus arteriosus with interrupted aortic arch  
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Table 6: Risk factors for reoperation 
Variable Univariate Multivariate 
 p value HR        95% CI         p value         
Age at operation (days) 0.26    
Weight at operation (kg) 0.30    
TA-IAA  0.29    
Coronary artery anomaly 0.25    
Conduit material     
     Aortic homograft 0.038 3.1 1.3-7.7 0.015 
     Pulmonary homograft 0.33 1.8 0.9-3.6 0.099 
Conduit size 
Decade† 
     1980s 
     1990s 






0.7 0.6-0.9 <0.001 
* Compared to bovine jugular vein conduit (BJVC) 
†Compared to 2010s 




Figure 1: Era analysis of conduit material used for RVOT reconstruction 
Figure 2: Kaplan-Meier analysis of freedom from reoperation (Aortic: aortic homograft; BJVC: bovine 
jugular venous conduit; Pulmonary: pulmonary homograft) 


